Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22430271 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
Conditions: Kaposi's Sarcoma;   HIV Infections;   HIV Seronegativity
Intervention: Biological: Bevacizumab

Indicates status has not been verified in more than two years